Assessment of Disease‐Related Therapeutic Protein Drug‐Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis-Reference-Cited by-同舟云学术

Assessment of Disease‐Related Therapeutic Protein Drug‐Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis

Published:2016-01-11 Issue:6 Volume:56 Page:693-704
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Wei Xiaohui¹,Kenny Jane R.²,Dickmann Leslie¹,Maciuca Romeo³,Looney Caroline⁴,Tang Meina T.¹

Affiliation:

1. Clinical Pharmacology Genentech, Inc South San Francisco CA USA

2. Drug Metabolism and Pharmacokinetics Genentech, Inc South San Francisco CA USA

3. Biometrics Genentech, Inc South San Francisco CA USA

4. Biomarkers Genentech, Inc South San Francisco CA 94080 USA

Funder

Genentech, Inc

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.649

Reference54 articles.

1. AAPS Workshop Report: Strategies to Address Therapeutic Protein–Drug Interactions during Clinical Development

2. Risk-based strategy for the assessment of pharmacokinetic drug–drug interactions for therapeutic monoclonal antibodies

3. Regulation of cytochrome p450 by inflammatory mediators: why and how?;Morgan ET.;Drug Metab Dispos,2001

4. Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics

5. Gene-Specific Effects of Inflammatory Cytokines on Cytochrome P450 2C, 2B6 and 3A4 mRNA Levels in Human Hepatocytes

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of CYP3A in Health and Disease;Biomedicines;2022-10-24

2. Risk assessment of drug–drug interaction potential for bintrafusp alfa with cytochrome P4503A4 substrates: A totality of evidence approach;Clinical and Translational Science;2022-10-06

3. Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases;Clinical Pharmacology in Drug Development;2020-12-16

4. Protein drug-drug interactions for therapeutic modalities;Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters;2020

5. Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti-β7 integrin therapy for inflammatory bowel disease;Alimentary Pharmacology & Therapeutics;2018-03-30